AGP Picks
View all

Today in Healthcare
Provided by AGP

Today in Healthcare: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Healthcare.

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

Press releases published on June 2, 2026

Soleo Health Acquires Realo Specialty Care Pharmacy and BluHaven Management, Expanding Footprint in Mid-Atlantic Region
Jun. 2, 2026

Soleo Health Acquires Realo Specialty Care Pharmacy and BluHaven Management, Expanding Footprint in Mid-Atlantic Region

Indeterminate GlobeNewswire
Rezolute Announces Positive Interim Data for its Phase 3 upLIFT Study of Ersodetug in Tumor Hyperinsulinism
Jun. 2, 2026

Rezolute Announces Positive Interim Data for its Phase 3 upLIFT Study of Ersodetug in Tumor Hyperinsulinism

Indeterminate GlobeNewswire
Can-Fite Reports Positive Clinical Observation in Phase 2a Pancreatic Cancer Study and Highlights Namodenoson’s RAS Signaling Inhibition Mechanism
Jun. 2, 2026

Can-Fite Reports Positive Clinical Observation in Phase 2a Pancreatic Cancer Study and Highlights Namodenoson’s RAS Signaling Inhibition Mechanism

Indeterminate GlobeNewswire
Digital World Industry to Reach $726.7 Billion by 2030, Driven by Quantum Sensing and AI Commercialization
Jun. 2, 2026

Digital World Industry to Reach $726.7 Billion by 2030, Driven by Quantum Sensing and AI Commercialization

Indeterminate GlobeNewswire
Bluejay Diagnostics and Argonaut Manufacturing Services Announce Strategic Partnership
Jun. 2, 2026

Bluejay Diagnostics and Argonaut Manufacturing Services Announce Strategic Partnership

Indeterminate GlobeNewswire
FDA Grants Fast Track Designation to Merakris’ MTX-001, Opening Potential Accelerated Path to Market for Venous Leg Ulcer Therapy
Jun. 2, 2026

FDA Grants Fast Track Designation to Merakris’ MTX-001, Opening Potential Accelerated Path to Market for Venous Leg Ulcer Therapy

Indeterminate GlobeNewswire
The Ensign Group Acquires Real Estate and Operations in Iowa
Jun. 2, 2026

The Ensign Group Acquires Real Estate and Operations in Iowa

Indeterminate GlobeNewswire
The Ensign Group Purchases Memory Care Facility in California
Jun. 2, 2026

The Ensign Group Purchases Memory Care Facility in California

Indeterminate GlobeNewswire
Herantis reports positive FDA feedback and finalizes Phase 2a study design for HER-096
Jun. 2, 2026

Herantis reports positive FDA feedback and finalizes Phase 2a study design for HER-096

Indeterminate GlobeNewswire
Propanc Biopharma’s CEO Attends Keynote Address, “Rejuvenation and Health: Science for an Ageing Society,” at the University of Granada, Spain
Jun. 2, 2026

Propanc Biopharma’s CEO Attends Keynote Address, “Rejuvenation and Health: Science for an Ageing Society,” at the University of Granada, Spain

Indeterminate GlobeNewswire
Crinetics’ Paradigm-Shifting Portfolio and Pipeline on Display at ENDO 2026 with Six Presentations
Jun. 2, 2026

Crinetics’ Paradigm-Shifting Portfolio and Pipeline on Display at ENDO 2026 with Six Presentations

Indeterminate GlobeNewswire
Philips announces exchange ratio for 2025 dividend
Jun. 2, 2026

Philips announces exchange ratio for 2025 dividend

Indeterminate GlobeNewswire
Comen Launches Latin American Medical Solutions at Hospitalar 2026
Jun. 2, 2026

Comen Launches Latin American Medical Solutions at Hospitalar 2026

Indeterminate GlobeNewswire
FundaMental Pharma appoints depression drug developer Dr. Hans Eriksson as Chief Medical Officer to advance its lead treatment-resistant depression candidate
Jun. 2, 2026

FundaMental Pharma appoints depression drug developer Dr. Hans Eriksson as Chief Medical Officer to advance its lead treatment-resistant depression candidate

Indeterminate GlobeNewswire
Nanobiotix Joins the Euronext Tech Leaders Index
Jun. 2, 2026

Nanobiotix Joins the Euronext Tech Leaders Index

Indeterminate GlobeNewswire
Nanobiotix rejoint l'indice Euronext Tech Leaders
Jun. 2, 2026

Nanobiotix rejoint l'indice Euronext Tech Leaders

Indeterminate GlobeNewswire
OXB Capital Markets Event
Jun. 2, 2026

OXB Capital Markets Event

Indeterminate GlobeNewswire
Greywolf Therapeutics reports durable clinical responses with first-in-class oral ERAP1 inhibitor GRWD5769 across six solid tumor types
Jun. 2, 2026

Greywolf Therapeutics reports durable clinical responses with first-in-class oral ERAP1 inhibitor GRWD5769 across six solid tumor types

Indeterminate GlobeNewswire
Launch of TechBio firm, Lucera, brings decision intelligence to drug development, making it more predictable, more evidence-grounded, and more efficient
Jun. 2, 2026

Launch of TechBio firm, Lucera, brings decision intelligence to drug development, making it more predictable, more evidence-grounded, and more efficient

Indeterminate GlobeNewswire
Inventiva Announces Temporary Trading Halt of its Ordinary Shares on Euronext Paris
Jun. 2, 2026

Inventiva Announces Temporary Trading Halt of its Ordinary Shares on Euronext Paris

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Today in Healthcare

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.